Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
The divergence between large and small holders has historically preceded further downside, with the Crypto Fear and Greed Index dropping to 12...
Traders are watching whether the $1.35 support zone holds after high-volume selling earlier in the session....
https://www.theamericanconservative.com/an-extended-war-with-iran-will-weaken-american-deterrence-against-china-and-russia/...
